Theravance Biopharma Cash Flow Statement (2013-2026) | TBPH

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
12.45M20.60M25.78M15.59M18.38M927.09M3.89M-22.09M-15.64M-8.95M-8.49M-11.66M-16.53M-12.70M23.53M-13.58M54.84M3.61M-58.89M-4.97M
Share-based Compensation (Quarter)
14.94M14.37M16.92M14.54M9.71M8.53M6.95M7.02M6.26M6.26M5.82M5.23M5.38M4.96M5.83M4.88M4.54M4.58M4.48M4.50M
Deferred Taxes (Quarter)
-0.51M-0.56M0.09M-6.59M-1.85M-10.69M0.99M0.03M-3.00M
Cash from Discontinued Operations (Quarter)
2.82M0.61M-1.00M-5.21M-178.97M
Gains from Sales and Divestitures (Quarter)
0.41M3.77M1.65M0.66M0.36M0.30M1.64M0.62M0.41M0.34M1.83M0.72M
Gains from Investment Securities (Quarter)
0.34M0.50M0.46M0.15M0.04M0.07M0.99M0.08M0.05M0.19M0.01M2.30M2.26M1.90M0.53M1.90M0.17M1.98M-1.69M0.00M
Asset Writedowns and Impairment (Quarter)
1.56M-0.01M
Non-cash Items (Quarter)
1.07M0.78M0.86M1.82M
Cash from Operations (Quarter)
-50.11M-45.45M-42.43M-26.07M-14.34M-22.53M-124.06M-11.22M-12.44M-2.49M-0.85M-1.02M-4.42M-5.20M-0.90M43.04M208.07M-6.51M-6.06M73.28M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
1.01M1.01M1.03M0.34M0.97M0.97M1.71M1.03M0.79M0.91M1.43M1.10M1.13M1.13M1.05M0.97M0.94M1.00M1.11M1.06M
Depreciation & Amortization (CF) (Quarter)
1.39M1.62M0.25M0.98M0.97M1.11M0.66M0.62M0.55M0.43M0.39M0.43M0.43M0.43M0.42M0.41M0.41M0.41M0.40M0.38M
Change in Working Capital
Change in Receivables (Quarter)
Change in Inventory (Quarter)
Change in Account Payables (Quarter)
5.10M-1.82M-5.74M-1.62M1.59M2.18M-3.76M1.00M-0.92M0.27M-0.35M0.18M-0.00M-0.22M0.79M0.17M-0.73M0.54M0.35M-1.47M
Change in Accured Expenses (Quarter)
17.23M-36.50M-0.65M-10.34M-0.79M-7.33M17.22M-4.34M-2.20M-0.12M-0.44M-3.40M1.14M0.73M2.99M-1.51M3.19M3.61M-1.27M-4.87M
Change in Taxes (Quarter)
-22.62M
Other Working Capital Changes (Quarter)
-1.98M6.63M-12.24M-1.72M1.80M-1.19M0.59M-1.27M0.79M0.46M-2.98M0.01M0.20M0.36M-0.57M-0.15M0.05M0.01M6.30M0.02M
Investing Activities
Capital Expenditures (Quarter)
0.16M1.04M0.44M0.25M0.11M-0.06M0.27M0.94M0.85M0.02M0.68M0.09M0.04M0.01M0.19M0.01M
Sales of Property, Plant and Equipment (Quarter)
1.85M0.02M0.21M1.30M
Divestments (Quarter)
-1092.42M
Change in Acquisitions & Divestments (Quarter)
75.90M30.00M64.80M48.50M43.20M17.00M49.30M29.50M41.88M44.02M28.24M27.50M40.05M32.60M20.35M24.50M65.53M96.00M
Cash from Investing Activities (Quarter)
35.77M-35.79M10.82M31.92M7.51M-19.73M1,134.30M-43.05M11.05M-0.02M-0.68M17.03M-3.03M-17.40M15.69M30.63M-36.26M-100.25M0.59M52.59M
Financing Activities
Other financing activities (Quarter)
0.73M2.29M0.46M1.45M0.35M0.66M23.64M0.89M0.58M0.51M0.52M1.27M0.46M0.40M0.53M0.87M0.50M0.68M1.98M5.82M
Cash from Financing Activities (Quarter)
105.28M-2.29M0.15M-1.45M0.14M-701.84M-35.47M-56.24M-80.68M-31.40M-30.61M-1.72M-0.04M-0.37M-0.36M-0.85M-0.50M-0.40M-1.49M-5.58M
Additional items
Change in Cash (Quarter)
90.94M-83.53M-31.46M4.41M-7.08M331.25M-120.37M-110.51M-82.07M-33.91M-32.14M14.29M-7.49M-22.97M14.42M72.82M171.31M-107.15M-6.97M120.30M
Free Cash Flow (Quarter)
-50.27M-46.48M-42.88M-26.32M-14.45M-22.47M-124.32M-12.16M-13.29M-2.51M-1.53M-1.11M-4.45M-5.21M-1.09M43.04M208.07M-6.51M-6.07M73.28M
Net Cash Flow (Quarter)
90.94M-83.53M-31.46M4.41M-6.69M-744.09M974.77M-110.51M-82.07M-33.91M-32.14M14.29M-7.49M-22.97M14.42M72.82M171.31M-107.15M-6.97M120.30M